TransEnterix (TRXC) Stock Price Down 1%

TransEnterix, Inc. (NYSEAMERICAN:TRXC) was down 1% on Wednesday . The company traded as low as $3.05 and last traded at $3.07. Approximately 101,355 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 2,636,358 shares. The stock had previously closed at $3.10.

TRXC has been the topic of several analyst reports. BTIG Research upgraded shares of TransEnterix from a “neutral” rating to a “buy” rating in a research note on Wednesday, May 9th. Zacks Investment Research downgraded shares of TransEnterix from a “hold” rating to a “sell” rating in a research note on Thursday, March 8th.

Get TransEnterix alerts:

TransEnterix (NYSEAMERICAN:TRXC) last issued its earnings results on Tuesday, May 8th. The medical instruments supplier reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01. The firm had revenue of $4.77 million for the quarter, compared to the consensus estimate of $3.81 million. TransEnterix had a negative net margin of 21,045.36% and a negative return on equity of 137.69%.

Several hedge funds and other institutional investors have recently modified their holdings of TRXC. Virtu Financial LLC bought a new position in TransEnterix during the fourth quarter valued at approximately $109,000. Raymond James Financial Services Advisors Inc. bought a new position in TransEnterix during the fourth quarter valued at approximately $113,000. Barclays PLC bought a new position in TransEnterix during the first quarter valued at approximately $164,000. Bank of New York Mellon Corp lifted its position in TransEnterix by 94.0% during the fourth quarter. Bank of New York Mellon Corp now owns 119,584 shares of the medical instruments supplier’s stock valued at $231,000 after purchasing an additional 57,944 shares during the period. Finally, Iguana Healthcare Management LLC bought a new position in TransEnterix during the fourth quarter valued at approximately $241,000.

About TransEnterix

TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.